Keywords: astra, restructuring, hits, profits, losec, drives, sales
Astra's Restructuring Hits Profits As Losec Drives Sales
Article | 03 November 1998
Swedish pharmaceutical group Astra has posted pretax profits of 3.01billion Swedish kroner ($385.5 million) for the third quarter of 1998, a fall ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Pfizer to split-off remaining 80% interest in Zoetis
